Maharashtra Food and Drug Administration (FDA) Minister Narhari Zirwal on Friday, 4 July 2025, categorically ruled out any privatisation of the Haffkine Bio-Pharmaceutical Corporation in the state Assembly, announcing instead a comprehensive government-backed revival roadmap for the century-old vaccine maker. The assurance came in response to a question raised by Congress MLA Jyoti Gaikwad, with several senior legislators joining the debate over the institute's prolonged stagnation.

What the Government Has Promised

Minister Zirwal confirmed that Chief Minister Devendra Fadnavis will shortly chair a stakeholder meeting to clear immediate development bottlenecks. A full-time IAS officer will be appointed as Managing Director to overhaul the institute's administration. The comprehensive restructuring report prepared by the high-powered Dr R.A. Mashelkar Committee will be formally tabled before the House.

A detailed funding proposal worth ₹150 crore — previously submitted to the Finance Department — is being resubmitted after rectifying administrative technicalities, the minister stated.

The ₹1,100 Crore Mashelkar Blueprint

Both ruling and Opposition legislators noted that Haffkine — despite its 100-plus-year legacy as a premier vaccine manufacturer — completely halted production of the DPT (Diphtheria, Pertussis, and Tetanus) vaccine in 2007, owing to the absence of modernised manufacturing infrastructure. The Mashelkar Committee has responded with a ₹1,100 crore master plan covering five critical projects: the Inactivated Polio Vaccine (IPV) plant, a Pentavalent vaccine facility, a tissue-culture anti-rabies vaccine unit, modernisation of the Pimpri anti-venom and serum facility, and production of bio-engineered blood clotting factors.

Under the proposed funding structure, the Maharashtra government would contribute ₹100 crore as equity, with the Central Government providing the balance. In the near term, Haffkine has sought a fast-tracked allocation of ₹50 crore for the polio vaccine plant and ₹100 crore for the Pimpri serum unit's modernisation, according to the department.

Senior legislators including Dilip Walse Patil, Vijay Wadettiwar, Atul Bhatkhalkar, and Yogesh Sagar participated in the discussion, flagging concerns over the pace of revival at an institution that once supplied vaccines to the nation.

ESI Hospitals to Get Advanced Medical Technology

In the state Legislative Council, Public Health Minister Prakash Abitkar announced that Maharashtra is actively deploying advanced medical technologies across all Employees' State Insurance (ESI) hospitals to make healthcare faster, more accessible, and higher in quality. He was responding to a question by MLC Manisha Kayande, with sub-questions from Bhai Jagtap, Prasad Lad, and Rajiv Potdar.

Minister Abitkar emphasised that workers enrolled under the ESI scheme receive completely free medical treatment and urged elected representatives to amplify awareness of these entitlements. On procurement transparency, he stated that quality will be the overriding criterion in purchase guidelines, with Public Sector Undertakings (PSUs) actively involved where applicable.

Amravati Medical College Awaits Forest Clearance

Medical Education Minister Hasan Mushrif told the Legislative Council that the permanent campus of the Amravati Government Medical College cannot be finalised until environmental clearances are received from the Central Government. The state had identified and taken possession of a land parcel in Aliyabad, but subsequent surveys established that the site falls within a protected forest zone.

Minister Mushrif clarified that the National Medical Commission (NMC) mandates every government medical college be co-located with a minimum 500-bed hospital, ruling out remote alternative sites. The college will remain within or on the immediate periphery of Amravati city. Administrative procedures to clear forest department hurdles are being expedited, and local leadership meetings will be convened shortly to address faculty and contractual staff requirements in the interim. The issue was raised by NCP MLA Sanjay Khodke, supported by Bachchu Kadu and Aniket Tatkare.

What Happens Next

With CM Fadnavis's stakeholder meeting imminent and the ₹150 crore proposal back in motion, the immediate test is whether Haffkine's decades-long production paralysis can finally be reversed. The Mashelkar Committee's ₹1,100 crore blueprint offers a credible path — but execution timelines and Centre-state fund-sharing remain to be formalised. For ESI beneficiaries and Amravati's medical aspirants, the government's commitments now await follow-through on the ground.